Identification of creatine kinase and alpha-1 antitrypsin as protein targets of alkylation by sulfur mustard.


Journal

Drug testing and analysis
ISSN: 1942-7611
Titre abrégé: Drug Test Anal
Pays: England
ID NLM: 101483449

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 21 07 2020
revised: 16 08 2020
accepted: 18 08 2020
pubmed: 28 8 2020
medline: 25 2 2023
entrez: 28 8 2020
Statut: ppublish

Résumé

Sulfur mustard (SM) is a toxic chemical warfare agent deployed in several conflicts within the last 100 years and still represents a threat in terroristic attacks and warfare. SM research focuses on understanding the pathophysiology of SM and identifying novel biomarkers of exposure. SM is known to alkylate nucleophilic moieties of endogenous proteins, for example, free thiol groups of cysteine residues. The two-dimensional-thiol-differences in gel electrophoresis (2D-thiol-DIGE) technique is an initial proteomics approach to detect proteins with free cysteine residues. These amino acids are selectively labeled with infrared-maleimide dyes visualized after GE. Cysteine residues derivatized by alkylating agents are no longer accessible for the maleimide-thiol coupling resulting in the loss of the fluorescent signal of the corresponding protein. To prove the applicability of 2D-thiol-DIGE, this technology was exemplarily applied to neat human serum albumin treated with SM, to lysates from human cell culture exposed to SM as well as to human plasma exposed to CEES (chloroethyl ethyl sulfide, an SM analogue). Exemplarily, the most prominent proteins modified by SM were identified by matrix-assisted laser desorption/ionization time-of-flight (tandem) mass spectrometry, MALDI-TOF MS(/MS), as creatine kinase (CK) from human cells and as alpha-1 antitrypsin (A1AT) from plasma samples. Peptides containing the residue Cys

Identifiants

pubmed: 32852113
doi: 10.1002/dta.2916
doi:

Substances chimiques

Chemical Warfare Agents 0
alpha 1-Antitrypsin 0
Creatine Kinase EC 2.7.3.2
Mustard Gas T8KEC9FH9P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

268-282

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : Research Training Group GRK 2338

Informations de copyright

© 2020 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.

Références

Azizi F, Keshavarz A, Roshanzamir F, Nafarabadi M. Reproductive function in men following exposure to chemical warfare with sulphur mustard. Med War. 1995;11(1):34-44. https://doi.org/10.1080/07488009508409195
Saladi RN, Smith E, Persaud AN. Mustard: a potential agent of chemical warfare and terrorism. Clin Exp Dermatol. 2006;31(1):1-5. https://doi.org/10.1111/j.1365-2230.2005.01945.x
John H, Koller M, Worek F, Thiermann H, Siegert M. Forensic evidence of sulfur mustard exposure in real cases of human poisoning by detection of diverse albumin-derived protein adducts. Arch Toxicol. 2019;93(7):1881-1891. https://doi.org/10.1007/s00204-019-02461-2
Sezigen S, Ivelik K, Ortatatli M, et al. Victims of chemical terrorism, a family of four who were exposed to sulfur mustard. Toxicol Lett. 2019;303:9-15. https://doi.org/10.1016/j.toxlet.2018.12.006
Sezigen S, Eyison RK, Kilic E, Kenar L. Evidence of sulfur mustard exposure in victims of chemical terrorism by detection of urinary β-lyase metabolites. Clin Toxicol (Phila). 2020;58(1):36-44. https://doi.org/10.1080/15563650.2019.1614190
Sezigen S, Kenar L. Recent sulfur mustard attacks in Middle East and experience of health professionals. Toxicol Lett. 2020;320:52-57. https://doi.org/10.1016/j.toxlet.2019.12.001
Schmidt A, Steinritz D, Rudolf K-D, Thiermann H, Striepling E. Accidental sulfur mustard exposure: a case report. Toxicol Lett. 2018;293:62-66. https://doi.org/10.1016/j.toxlet.2017.11.023
Steinritz D, Striepling E, Rudolf KD, et al. Medical documentation, bioanalytical evidence of an accidental human exposure to sulfur mustard and general therapy recommendations. Toxicol Lett. 2016;244:112-120. https://doi.org/10.1016/j.toxlet.2015.08.1105
Siegert M, Kranawetvogl A, Thiermann H, John H. Glutathione as an antidote for sulfur mustard poisoning: mass spectrometric investigations of its potency as a chemical scavenger. Toxicol Lett. 2018;293:31-37. https://doi.org/10.1016/j.toxlet.2017.12.013
Siegert M, Kranawetvogl A, Thiermann H, John H. N-Acetylcysteine as a chemical scavenger for sulfur mustard: new insights by mass spectrometry. Drug Test Anal. 2018;10(2):243-253. https://doi.org/10.1002/dta.2299
Zubel T, Bürkle A, Mangerich A. Mass spectrometric analysis of sulfur mustard-induced biomolecular adducts: are DNA adducts suitable biomarkers of exposure? Toxicol Lett. 2018;293:21-30. https://doi.org/10.1016/j.toxlet.2017.12.014
Lüling R, Singer H, Popp T, et al. Sulfur mustard alkylates steroid hormones and impacts hormone function in vitro. Arch Toxicol. 2019;93(11):3141-3152. https://doi.org/10.1007/s00204-019-02571-x
John H, Balszuweit F, Steinritz D, Kehe K, Worek F, Thiermann H. Toxicokinetic aspects of nerve agents and vesicants. In: Gupta RC, ed. Handbook of Toxicology of Chemical Warfare Agent. 3rd ed. San Diego, USA: Elsevier; 2020:875-919.
Noort D, Hulst AG, de Jong LP, Benschop HP. Alkylation of human serum albumin by sulfur mustard in vitro and in vivo: mass spectrometric analysis of a cysteine adduct as a sensitive biomarker of exposure. Chem Res Toxicol. 1999;12(8):715-721. https://doi.org/10.1021/tx9900369
Gandor F, Gawlik M, Thiermann H, John H. Evidence of sulfur mustard exposure in human plasma by LC-ESI-MS-MS detection of the albumin-derived alkylated HETE-CP dipeptide and chromatographic investigation of its cis/trans isomerism. J Anal Toxicol. 2015;39(4):270-279. https://doi.org/10.1093/jat/bkv010
John H, Siegert M, Gandor F, et al. Optimized verification method for detection of an albumin-sulfur mustard adduct at Cys34 using a hybrid quadrupole time-of-flight tandem mass spectrometer after direct plasma proteolysis. Toxicol Lett. 2016;244:103-111. https://doi.org/10.1016/j.toxlet.2015.09.027
Dillman JF, McGary KL, Schlager JJ. Sulfur mustard induces the formation of keratin aggregates in human epidermal keratinocytes. Toxicol Appl Pharmacol. 2003;193(2):228-236. https://doi.org/10.1016/j.taap.2003.08.003
Lawley PD, Brookes P. Interstrand cross-linking of DNA by difunctional alkylating agents. J Mol Biol. 1967;25(1):143-160. https://doi.org/10.1016/0022-2836(67)90285-9
Mol MAE, van der Schans GP, Lohman P. Quantification of sulfur mustard-induced DNA interstrand cross-links and single-strand breaks in cultured human epidermal keratinocytes. Mutat Res-DNA Repair. 1993;294(3):235-245. https://doi.org/10.1016/0921-8777(93)90006-3
Sack GH, Fenselau C, Kan M-NN, Kan LS, Wood GW, Lau P-Y. Characterization of the products of alkylation of 2′-deoxyadenosine and 2′-deoxyguanosine by chloroethyl ethyl sulfide. J Org Chem. 1978;43(20):3932-3936. https://doi.org/10.1021/jo00414a028
Hiscock JR, Bustone GP, Clark ER. Decontamination and remediation of the sulfur mustard simulant CEES with "off-the-shelf" reagents in solution and gel states: a proof-of-concept study. Chem. 2017;6(4):497-500. https://doi.org/10.1002/open.201700063
An W-H, Zhong Y-X, Ying X-Y, Shi H-N, Ying Y. Identification of differential proteins of pinnal skin of mice poisoned by sulfur mustard. Chin J Pharmacol Toxicol. 2006;20:152-156.
Lüling R, John H, Gudermann T, et al. Transient receptor potential channel A1 (TRPA1) regulates sulfur mustard-induced expression of heat shock 70 kDa protein 6 (HSPA6) in vitro. Cell. 2018;7(9):126. https://doi.org/10.3390/cells7090126
Panahi Y, Abdolghaffari AH, Sahebkar A. A review on symptoms, treatments protocols, and proteomic profile in sulfur mustard-exposed victims. J Cell Biochem. 2018;119(1):197-206. https://doi.org/10.1002/jcb.26247
David J, John H. Chapter 7. The impact of new technologies on the elucidation of chemical warfare agent toxicology. In: Worek F, Thiermann H, Jenner J, eds. Chemical warfare toxicology: Volume 2: Management of poisoning. Vol.2 Cambridge: Royal Society of Chemistry; 2016:219-258.
Mol MAE, van den Berg RM, Benschop HP. Proteomic assessment of sulfur mustard-induced protein adducts and other protein modifications in human epidermal keratinocytes. Toxicol Appl Pharmacol. 2008;230(1):97-108. https://doi.org/10.1016/j.taap.2008.02.006
Mandal N, Heegaard S, Prause JU, Honoré B, Vorum H. Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry. Biol Proced Online. 2009;12(1):56-88. https://doi.org/10.1007/s12575-009-9019-7
Tannu NS, Hemby SE. Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling. Nat Protoc. 2006;1(4):1732-1742. https://doi.org/10.1038/nprot.2006.256
Riederer IM, Riederer BM. Differential protein labeling with thiol-reactive infrared DY-680 and DY-780 maleimides and analysis by two-dimensional gel electrophoresis. Proteomics. 2007;7(11):1753-1756. https://doi.org/10.1002/pmic.200601007
Manandhar E, Pay A, Veress LA, Logue BA. Rapid analysis of sulfur mustard oxide in plasma using gas chromatography-chemical ionization-mass spectrometry for diagnosis of sulfur mustard exposure. J Chromatogr A. 2018;1572:106-111. https://doi.org/10.1016/j.chroma.2018.08.035
Thomas P, Smart TG. HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods. 2005;51(3):187-200. https://doi.org/10.1016/j.vascn.2004.08.014
Stenger B, Zehfuss F, Mückter H, et al. Activation of the chemosensing transient receptor potential channel A1 (TRPA1) by alkylating agents. Arch Toxicol. 2015;89(9):1631-1643. https://doi.org/10.1007/s00204-014-1414-4
Bickerstaff GF, Price NC. Creatine kinase: a review of some recent work on the mechanism and subunit behaviour of the enzyme. Int J Biochem. 1978;9(1):1-8. https://doi.org/10.1016/0020-711X(78)90128-3
Gupta RC, Lasher MA, Doss RB, Milatovic D. Skeletal muscle toxicity biomarkers. In: Gupta RC, ed. Biomarkers in Toxicology. Burlington: Elsevier Science; 2014:291-308.
Gupta RC, Zaja-Milatovic S, Dettbarn W-D, Malik JK. Skeletal muscle. In: Gupta RC, ed. Handbook of Toxicology of Chemical Warfare Agents. Second ed. London: Elsevier/Academic Press; 2015:577-597.
Berridge BR, van Vleet JF, Herman E. Cardiac, vascular, and skeletal muscle systems. In: Haschek WM, ed. Handbook of Toxicologic Pathology. 3rd ed. Amsterdam: Elsevier; 2013:1567-1665.
McLaughlin RM, Fish RE. Clinical biochemistry and hematology. In: Manning PJ, ed. The Biology of the Laboratory Rabbit. 2nd ed. [Nachdr.]. San Diego: Acad. Press; 1997:111-127.
Schlattner U, Möckli N, Speer O, Werner S, Wallimann T. Creatine kinase and creatine transporter in normal, wounded, and diseased skin. J Invest Dermatol. 2002;118(3):416-423. https://doi.org/10.1046/j.0022-202x.2001.01697.x
Lenz H, Schmidt M, Welge V, et al. The creatine kinase system in human skin: protective effects of creatine against oxidative and UV damage in vitro and in vivo. J Invest Dermatol. 2005;124(2):443-452. https://doi.org/10.1111/j.0022-202X.2004.23522.x
Reddy S, Jones AD, Cross CE, Wong PS, van der Vliet A. Inactivation of creatine kinase by S-glutathionylation of the active-site cysteine residue. Biochem J. 2000;347(Pt 3):821-827. https://doi.org/10.1042/bj3470821
Furter R, Furter-Graves EM, Wallimann T. Creatine kinase: the reactive cysteine is required for synergism but is nonessential for catalysis. Biochemistry. 1993;32(27):7022-7029. https://doi.org/10.1021/bi00078a030
Wang PF, McLeish MJ, Kneen MM, Lee G, Kenyon GL. An unusually low pKa for Cys282 in the active site of human muscle creatine kinase. Biochemistry. 2001;40(39):11698-11705. https://doi.org/10.1021/bi011208f
Wang PF, Flynn AJ, Naor MM, et al. Exploring the role of the active site cysteine in human muscle creatine kinase. Biochemistry. 2006;45(38):11464-11472. https://doi.org/10.1021/bi0607002
Naor MM, Jensen JH. Determinants of cysteine pKa values in creatine kinase and a1-antitrypsin. Proteins: Struct Funct Bioinform. 2004;57(4):799-803. https://doi.org/10.1002/prot.20261
Eder M, Schlattner U, Becker A, Wallimann T, Kabsch W, Fritz-Wolf K. Crystal structure of brain-type creatine kinase at 1.41 A resolution. Protein Sci. 1999;8(11):2258-2269. https://doi.org/10.1110/ps.8.11.2258
Rao JKM, Bujacz G, Wlodawer A. Crystal structure of rabbit muscle creatine kinase. FEBS Lett. 1998;439(1-2):133-137. https://doi.org/10.1016/s0014-5793(98)01355-6
Shen YQ, Tang L, Zhou HM, Lin ZJ. Structure of human muscle creatine kinase. Acta Crystallogr D Biol Crystallogr. 2001;57(Pt 8):1196-1200. https://doi.org/10.1107/s0907444901007703
Witherspoon LR, Shuler SE, Genre CF, Mackenzie FJ, Garcia MM. Two radioimmunoassays compared with isoenzyme electrophoresis for the detection of serum creatine kinase-MB in acute myocardial infarction. J Nucl Med. 1982;23(2):136-142.
Gledhill RF, van der Merwe CA, Greyling M, van Niekerk MM. Race-gender differences in serum creatine kinase activity: a study among South Africans. J Neurol Neurosurg Psychiatry. 1988;51(2):301-304. https://doi.org/10.1136/jnnp.51.2.301
Mougios V. Reference intervals for serum creatine kinase in athletes. Br J Sports Med. 2007;41(10):674-678. https://doi.org/10.1136/bjsm.2006.034041
Yousef MA, Vaida S, Somri M, et al. Changes in creatine phosphokinase (CK) concentrations after minor and major surgeries in children. Br J Anaesth. 2006;96(6):786-789. https://doi.org/10.1093/bja/ael077
Spicer SS, Schulte BA. Creatine kinase in epithelium of the inner ear. J Histochem Cytochem. 1992;40(2):185-192. https://doi.org/10.1177/40.2.1313059
Yakub GP, Stadterman-Knauer KL. Immunomagnetic separation of pathogenic organisms from environmental matrices. Methods Mol Biol. 2004;268:189-197. https://doi.org/10.1385/1-59259-766-1:189
Hess JF, FitzGerald PG. Treatment of keratin intermediate filaments with sulfur mustard analogs. Biochem Biophys Res Commun. 2007;359(3):616-621. https://doi.org/10.1016/j.bbrc.2007.05.141
Pal A, Tewari-Singh N, Gu M, et al. Sulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice. Free Radic Biol Med. 2009;47(11):1640-1651. https://doi.org/10.1016/j.freeradbiomed.2009.09.011
Tewari-Singh N, Gu M, Agarwal C, White CW, Agarwal R. Biological and molecular mechanisms of sulfur mustard analogue-induced toxicity in JB6 and HaCaT cells: possible role of ataxia telangiectasia-mutated/ataxia telangiectasia-Rad3-related cell cycle checkpoint pathway. Chem Res Toxicol. 2010;23(6):1034-1044. https://doi.org/10.1021/tx100038b
Bennett RA, Behrens E, Zinn A, Duncheon C, Lamkin TJ. Mustard gas surrogate, 2-chloroethyl ethylsulfide (2-CEES), induces centrosome amplification and aneuploidy in human and mouse cells: 2-CEES induces centrosome amplification and chromosome instability. Cell Biol Toxicol. 2014;30(4):195-205. https://doi.org/10.1007/s10565-014-9279-0
Wang Q-Q, Begum RA, Day VW, Bowman-James K. Sulfur, oxygen, and nitrogen mustards: stability and reactivity. Org Biomol Chem. 2012;10(44):8786-8793. https://doi.org/10.1039/c2ob26482j
Heywood WE, Madgett TE, Wang D, et al. 2D DIGE analysis of maternal plasma for potential biomarkers of down syndrome. Proteome Sci. 2011;9(1):56. https://doi.org/10.1186/1477-5956-9-56
Insenser M, Martínez-García MÁ, Nieto RM, San-Millán JL, Escobar-Morreale HF. Impact of the storage temperature on human plasma proteomic analysis: implications for the use of human plasma collections in research. Proteomics Clin Appl. 2010;4(8-9):739-744. https://doi.org/10.1002/prca.201000007
Zhu K, Zhao J, Lubman DM, Miller FR, Barder TJ. Protein pI shifts due to posttranslational modifications in the separation and characterization of proteins. Anal Chem. 2005;77(9):2745-2755. https://doi.org/10.1021/ac048494w
Huber R, Carrell RW. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry. 1989;28(23):8951-8966. https://doi.org/10.1021/bi00449a001
Ossanna PJ, Test ST, Matheson NR, Regiani S, Weiss SJ. Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions. J Clin Invest. 1986;77(6):1939-1951. https://doi.org/10.1172/JCI112523
Teckman J. Alpha-1-antitrypsin deficiency liver desaese. In: Kalsheker N, Stockley RA, eds. Alpha-1-Antitrypsin Deficiency: Biology, Diagnosis, Clinical Significance, and Emerging Therapies. London: Academic Press an imprint of Elsevier; 2017:117-128.
Mitchell EL, Khan Z. Liver disease in Alpha-1 antitrypsin deficiency: current approaches and future directions. Curr Pathobiol Rep. 2017;5(3):243-252. https://doi.org/10.1007/s40139-017-0147-5
Griffiths SW, King J, Cooney CL. The reactivity and oxidation pathway of cysteine 232 in recombinant human alpha 1-antitrypsin. J Biol Chem. 2002;277(28):25486-25492. https://doi.org/10.1074/jbc.M203089200
Gilbert HF. Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzymol Relat Areas Mol Biol. 1990;63:69-172. https://doi.org/10.1002/9780470123096.ch2
Musiani P, Lauriola L, Piantelli M. Inhibitory activity of alpha-1-antitrypsin bound to human IgA. Clin Chim Acta. 1978;85(1):61-66. https://doi.org/10.1016/0009-8981(78)90101-8
Cantin AM, Woods DE, Cloutier D, Dufour EK, Leduc R. Polyethylene glycol conjugation at Cys232 prolongs the half-life of alpha1 proteinase inhibitor. Am J Respir Cell Mol Biol. 2002;27(6):659-665. https://doi.org/10.1165/rcmb.4866
Miyamoto Y, Akaike T, Maeda H. S-nitrosylated human α1-protease inhibitor. BBA-Protein Struct M. 2000;1477(1-2):90-97. https://doi.org/10.1016/S0167-4838(99)00264-2
Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med. 2011;105(8):1129-1139. https://doi.org/10.1016/j.rmed.2011.02.002

Auteurs

Robin Lüling (R)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität Munich, Munich, Germany.

Wolfgang Schmeißer (W)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.

Markus Siegert (M)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
Department of Chemistry, Humboldt-Universität zu Berlin, Berlin, Germany.

Harald Mückter (H)

Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität Munich, Munich, Germany.

Alexander Dietrich (A)

Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität Munich, Munich, Germany.

Horst Thiermann (H)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.

Thomas Gudermann (T)

Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität Munich, Munich, Germany.

Harald John (H)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.

Dirk Steinritz (D)

Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Bundeswehr Medical Service Academy, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH